MedTrace Logo

Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib

NCT00700687 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2009-01-12

No results posted yet for this study

Summary

We will evaluate the effect on the gastroduodenal mucosa from oral dosing of three different treatments

Conditions

  • Healthy

Interventions

DRUG

PA32540

aspirin/omeprazole

DRUG

PA32540 and celecoxib

aspirin/omeprazole and celecoxib

DRUG

aspirin and [NSAID]

aspirin and \[NSAID\]

Sponsors & Collaborators

  • POZEN

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00700687 on ClinicalTrials.gov